117 related articles for article (PubMed ID: 28347547)
21. Macrocyclization of a potent PACE4 inhibitor: Benefits and limitations.
Łepek T; Kwiatkowska A; Couture F; Ly K; Desjardins R; Dory Y; Prahl A; Day R
Eur J Cell Biol; 2017 Aug; 96(5):476-485. PubMed ID: 28483279
[TBL] [Abstract][Full Text] [Related]
22. PACE4-altCT isoform of proprotein convertase PACE4 as tissue and plasmatic biomarker for prostate cancer.
Couture F; Wang L; Dufour F; Chabot-Maheux K; Ekindi Ndongo N; Sabbagh R; Day R
Sci Rep; 2022 Apr; 12(1):6066. PubMed ID: 35410344
[TBL] [Abstract][Full Text] [Related]
23. Enhanced aggressiveness of benzopyrene-induced squamous carcinomas in transgenic mice overexpressing the proprotein convertase PACE4 (PCSK6).
Bassi DE; Cenna J; Zhang J; Cukierman E; Klein-Szanto AJ
Mol Carcinog; 2015 Oct; 54(10):1122-31. PubMed ID: 24845697
[TBL] [Abstract][Full Text] [Related]
24. Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1.
Lapierre M; Siegfried G; Scamuffa N; Bontemps Y; Calvo F; Seidah NG; Khatib AM
Cancer Res; 2007 Oct; 67(19):9030-4. PubMed ID: 17909005
[TBL] [Abstract][Full Text] [Related]
25. Pro-protein convertases (PCs) other than PC6 are not tightly regulated for implantation in the human endometrium.
Freyer C; Kilpatrick LM; Salamonsen LA; Nie G
Reproduction; 2007 Jun; 133(6):1189-97. PubMed ID: 17636173
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of PACE4 in prostate cancer is not dependent on E2F transcription factors.
Bakrania A; Aubé M; Desjardins R; Sabbagh R; Day R
Can J Physiol Pharmacol; 2020 Jul; 98(7):477-481. PubMed ID: 32119574
[TBL] [Abstract][Full Text] [Related]
27. Pro-protein convertase gene expression in human breast cancer.
Cheng M; Watson PH; Paterson JA; Seidah N; Chrétien M; Shiu RP
Int J Cancer; 1997 Jun; 71(6):966-71. PubMed ID: 9185698
[TBL] [Abstract][Full Text] [Related]
28. Knockdown strategies for the study of proprotein convertases and proliferation in prostate cancer cells.
D'Anjou F; Couture F; Desjardins R; Day R
Methods Mol Biol; 2014; 1103():67-82. PubMed ID: 24318887
[TBL] [Abstract][Full Text] [Related]
29. PACE4 regulates apoptosis in human pancreatic cancer Panc‑1 cells via the mitochondrial signaling pathway.
Tian XF; Huang GM; Zang HL; Cao H
Mol Med Rep; 2016 Dec; 14(6):5205-5210. PubMed ID: 27779720
[TBL] [Abstract][Full Text] [Related]
30. Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Convertases in HIV-Associated Neurocognitive Disorder.
Kim W; Zekas E; Lodge R; Susan-Resiga D; Marcinkiewicz E; Essalmani R; Mihara K; Ramachandran R; Asahchop E; Gelman B; Cohen ÉA; Power C; Hollenberg MD; Seidah NG
Mol Cell Biol; 2015 Nov; 35(21):3684-700. PubMed ID: 26283733
[TBL] [Abstract][Full Text] [Related]
31. Novel Insights into Structure-Activity Relationships of N-Terminally Modified PACE4 Inhibitors.
Kwiatkowska A; Couture F; Levesque C; Ly K; Beauchemin S; Desjardins R; Neugebauer W; Dory YL; Day R
ChemMedChem; 2016 Feb; 11(3):289-301. PubMed ID: 26751825
[TBL] [Abstract][Full Text] [Related]
32. The expression of proprotein convertase PACE4 is highly regulated by Hash-2 in placenta: possible role of placenta-specific basic helix-loop-helix transcription factor, human achaete-scute homologue-2.
Koide S; Yoshida I; Tsuji A; Matsuda Y
J Biochem; 2003 Sep; 134(3):433-40. PubMed ID: 14561729
[TBL] [Abstract][Full Text] [Related]
33. Endoproteolytic processing of integrin pro-alpha subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7.
Lissitzky JC; Luis J; Munzer JS; Benjannet S; Parat F; Chrétien M; Marvaldi J; Seidah NG
Biochem J; 2000 Feb; 346 Pt 1(Pt 1):133-8. PubMed ID: 10657249
[TBL] [Abstract][Full Text] [Related]
34. The paired basic amino acid-cleaving enzyme 4 (PACE4) is involved in the maturation of insulin receptor isoform B: an opportunity to reduce the specific insulin receptor-dependent effects of insulin-like growth factor 2 (IGF2).
Kara I; Poggi M; Bonardo B; Govers R; Landrier JF; Tian S; Leibiger I; Day R; Creemers JW; Peiretti F
J Biol Chem; 2015 Jan; 290(5):2812-21. PubMed ID: 25527501
[TBL] [Abstract][Full Text] [Related]
35. Rational Design of a Highly Potent and Selective Peptide Inhibitor of PACE4 by Salt Bridge Interaction with D160 at Position P3.
Dianati V; Shamloo A; Kwiatkowska A; Desjardins R; Soldera A; Day R; Dory YL
ChemMedChem; 2017 Aug; 12(15):1169-1172. PubMed ID: 28722823
[TBL] [Abstract][Full Text] [Related]
36. Proprotein convertase inhibition results in decreased skin cell proliferation, tumorigenesis, and metastasis.
Bassi DE; Zhang J; Cenna J; Litwin S; Cukierman E; Klein-Szanto AJ
Neoplasia; 2010 Jul; 12(7):516-26. PubMed ID: 20651981
[TBL] [Abstract][Full Text] [Related]
37. The proprotein convertases are potential targets in the treatment of dyslipidemia.
Seidah NG; Prat A
J Mol Med (Berl); 2007 Jul; 85(7):685-96. PubMed ID: 17351764
[TBL] [Abstract][Full Text] [Related]
38. Malignant conversion of non-tumorigenic murine skin keratinocytes overexpressing PACE4.
Mahloogi H; Bassi DE; Klein-Szanto AJ
Carcinogenesis; 2002 Apr; 23(4):565-72. PubMed ID: 11960907
[TBL] [Abstract][Full Text] [Related]
39. Proprotein convertase inhibition: Paralyzing the cell's master switches.
Klein-Szanto AJ; Bassi DE
Biochem Pharmacol; 2017 Sep; 140():8-15. PubMed ID: 28456517
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer.
Page RE; Klein-Szanto AJ; Litwin S; Nicolas E; Al-Jumaily R; Alexander P; Godwin AK; Ross EA; Schilder RJ; Bassi DE
Cell Oncol; 2007; 29(4):289-99. PubMed ID: 17641413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]